But Viral Rebound may actually be the smallest and one of the drug user's last concerns. Thus, the injecting drug user tends to feed back the infection itself.
And even if it unconsciously helps, the spread of HIV, the virus that can generate the AIDS What I want to clarify, with this text is that…
… When You Help Avoid Viral Rebound When Treating Chemical Addiction
- 1.1 Not “only in Brazil”! Antiretroviral therapy is provided free of charge to all people with HIV in Vancouver / Canada.
- 1.2 Knowing your immune condition is very important!
- 1.3 Outline IDU Social Profile Is Important in Fighting AIDS
- 1.4 Related
However, they have great difficulties in maintaining a viral load undetectable, Adams observed in the background.
Therefore, factors associated with viral recovery in previous studies include depression and other mental health problems.
Thus, we have, initially:
- intimate partner violence and
- stigma related to sex work.
Therefore, this analysis included 185 HIV-positive women using drugs who participated in the ACCESS prospective cohort study. Between 2005 and 2017. All started antiretroviral treatment and obtained viral suppression (HIV RNA below 50 copies / ml).
- almost half (46%) were indigenous.
- 25% identified as “Sexual minority” e
- 5% were transgender.
Participants were interviewed and received viral load and CD4 cell tests approximately every six months, with follow-up of up to 11 years.
But, I need to inform you, antiretroviral therapy is provided free of charge to all people with HIV in Vancouver. And to quote a friend from the past, Brazil is not the “only sponsor”.
Well, you already have an idea why "ex-friend". For he who spoke freely of everything desired my death! So I decided to die for him!
Just over a third (34%) of women experienced viral rebound, defined as HIV RNA above 1000 copies / ml. At least once during the 11 years of follow up.
Of these, two thirds had a viral rebound episode, one fourth had two of these events, and 8% had three or more episodes.
The researchers found that women who received consistent, drug-assisted treatment took longer to experience viral rebound.
Knowing your immune condition is very important!
Thus, they were more likely to maintain consistent viral suppression.
Comparing than those who never received MAT.
In both groups, the proportion that experienced viral recovery steadily increased during the first three years.
And soon after, they hit a plateau in the CD4 count.
Thus, among those followed for eight years or more, about 65% of women using medication-assisted treatment maintained viral suppression.
In comparison. of course, at about 55% of those not receiving MAT.
Outline IDU Social Profile Is Important in Fighting AIDS
Initially, it was necessary to adjust to a wide variety of factors:
- including race / ethnicity,
- sexual orientation,
- Education Level,
- sex work,
- injecting drug use,
- heavy use of alcohol,
- sexual abuse,
- structural violence.
- HIV Presence
- baseline viral load,
- as well as CD4 count.
The only factor considered protective against viral recovery was receiving drug-assisted addiction treatment during the past six months. But women who received MAT were about half as likely to get a viral rebound than women who did not (0,47 risk rate).
Therefore, adjusting antiretroviral adherence attenuated the effect of medication-assisted treatment, suggesting that MAT may have reduced the risk of viral rebound by increasing adherence.
"This study provides additional evidence that MAT can improve HIV treatment outcomes among women," the researchers concluded.
"Efforts to improve access and retention in MAT programs can improve viral suppression rates for HIV-infected women using illicit drugs."
Brazilian Pioneerism Makes Us the Best Examples of Good Results
They recommended that treatment of medication-assisted addiction be co-located in HIV treatment services, that MAT services have a low entry barrier, and that services include ART adherence counseling and support.
Translated by Claudio Souza's original Treating drug addiction may reduce risk of viral rebound
September 05th, 2019